Article citationsMore>>

Figueras, J., Baneras, J., Pena-Gil, C., Masip, J., Barrabes, J.A., Palomares, J.R. and Garcia-Dorado, D. (2016) Acute Arterial Hypertension in Acute Pulmonary Edema: Mostly a Trigger or an Associated Phenomenon. The Canadian Journal of Cardiology, 32, 1214-1220.
https://doi.org/10.1016/j.cjca.2015.10.030

has been cited by the following article:

• TITLE: Adverse Maternal Consequences Associated with Prolonged Acute-Onset Severe Systolic Hypertension during Pregnancy & Early Postpartum: Pitfalls in Practice & Lessons Learned

  AUTHORS: James Nello Martin Jr., James Martin Tucker

  KEYWORDS: Severe Systolic Hypertension Acute Pulmonary Edema Maternal Morbidity & Mortality Maternal Safety

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.11 No.5, May 27, 2021

  ABSTRACT: OBJECTIVE: To determine the types of major maternal-perinatal morbidity associated with prolonged, acute-onset severe systolic hypertension during pregnancy and postpartum. METHODS: A medicolegal database retaining only medical record data was created from all cases involving women with medical/hypertensive disorders of pregnancy evaluated by the first author between 1986-2015. Case files of women that experienced severe systolic hypertension (SSH) sustained for many hours to days were identified for study. RESULTS: Sixty six pregnant/postpartum women met study criteria. Stroke secondary to intracranial hemorrhage or thrombosis (65.2) and acute pulmonary edema (33%) were the leading causes of maternal morbidity and mortality, most often antepartum as a component of early-onset preeclampsia (≤34 weeks). Eclampsia, abruptio placenta and injury to heart, liver and/or kidneys were other frequent co-morbidities. Seven postpartum women developed sudden new-onset postpartum SSH and suffered a stroke 4 - 13 days after delivery. Maternal mortality (54.6%) and morbidity as persistent disability (24.2%) were high in this cohort. CONCLUSION: Failure to rapidly respond, reduce and sustain at a safe level acute-onset SSH poses a significant threat to the wellbeing of mothers and babies, before and in the weeks following delivery. Systems to implement safe practices to identify and emergently treat severe maternal hypertension are needed.